AR104445A2 - Compuestos inhibidores de la serina proteasa ns3 del vhc y composición farmacéutica - Google Patents

Compuestos inhibidores de la serina proteasa ns3 del vhc y composición farmacéutica

Info

Publication number
AR104445A2
AR104445A2 ARP160101214A ARP160101214A AR104445A2 AR 104445 A2 AR104445 A2 AR 104445A2 AR P160101214 A ARP160101214 A AR P160101214A AR P160101214 A ARP160101214 A AR P160101214A AR 104445 A2 AR104445 A2 AR 104445A2
Authority
AR
Argentina
Prior art keywords
alkyl
hcv
substituted
proteasa
serte
Prior art date
Application number
ARP160101214A
Other languages
English (en)
Spanish (es)
Inventor
Wallberg Hans
Samuelsson Bertil
Kvarnstrom Ingemar
Johansson Per
Ola - Thorstensson Frederik
Rosenquist Asa
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of AR104445A2 publication Critical patent/AR104445A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
ARP160101214A 2004-01-30 2016-04-28 Compuestos inhibidores de la serina proteasa ns3 del vhc y composición farmacéutica AR104445A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400199A SE0400199D0 (sv) 2004-01-30 2004-01-30 HCV Protease inhbitors

Publications (1)

Publication Number Publication Date
AR104445A2 true AR104445A2 (es) 2017-07-19

Family

ID=31713267

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160101214A AR104445A2 (es) 2004-01-30 2016-04-28 Compuestos inhibidores de la serina proteasa ns3 del vhc y composición farmacéutica

Country Status (5)

Country Link
CN (2) CN1914224B (no)
AR (1) AR104445A2 (no)
NO (1) NO340695B1 (no)
SE (1) SE0400199D0 (no)
ZA (1) ZA200607215B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070211A1 (es) * 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
CN108101811A (zh) * 2016-11-25 2018-06-01 斯福瑞(南通)制药有限公司 生产n-叔丁氧羰基-2-氨基-3,3-二甲基丁酸的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
US6323180B1 (en) * 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
MY140680A (en) * 2002-05-20 2010-01-15 Bristol Myers Squibb Co Hepatitis c virus inhibitors

Also Published As

Publication number Publication date
NO340695B1 (no) 2017-06-06
SE0400199D0 (sv) 2004-01-30
ZA200607215B (en) 2008-05-28
CN1914224A (zh) 2007-02-14
CN1914225B (zh) 2012-09-26
NO20063850L (no) 2006-08-29
CN1914224B (zh) 2014-01-29
CN1914225A (zh) 2007-02-14

Similar Documents

Publication Publication Date Title
EP1771454A4 (en) PEPTIDE ANALOGUE AS HEPATITIS C HEMMER
CY1113752T1 (el) Μακροκυκλικες ενωσεις κινοξαλινης ως αναστολεις πρωτεασεις ns3 του hcv
NO20056047L (no) Hepatitt C inhibitor forbindelser
TW200615275A (en) Hepatitis C inhibitor dipeptide analogs
ATE469155T1 (de) Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b- hemmer
ATE483712T1 (de) Hcv-ns5b-inhibitoren
EA200802346A1 (ru) Циклопропилконденсированные индолобензазепиновые ингибиторы белка ns5b вируса гепатита с
EA200600498A1 (ru) Макроциклические пептиды, проявляющие противовирусную активность в отношении вируса гепатита с
NO20075616L (no) Tripeptider som hepatitt C virus inhibitorer
ES2259113T3 (es) Inhibidores del factor xa y de otras serinproteasas implicadas en la cascada de coagulacion.
IL176237A0 (en) Inhibitors of hepatitis c virus ns3/ns4a serine protease
EA200400991A1 (ru) Фармацевтические композиции, содержащие ингибиторы протеазы вируса гепатита c
IL177627A0 (en) Novel compounds as inhibitors of hepatitis c virus ns3 serine protease
TNSN08033A1 (en) Hcv ns3 protease inhibitors
DK1481000T3 (da) Nye peptider som NS3-serin-proteasehæmmere af hepatitis C-virus
EA201190013A1 (ru) Ингибиторы ns5a вгс
EA200900969A1 (ru) Макроциклические ингибиторы протеазы гепатита с
WO2004101602A3 (en) Hepatitis c inhibitor peptide analogs
EA200900676A1 (ru) Ингибиторы вируса гепатита с
ATE492558T1 (de) Makrocyclische peptide als hepatitis-c-virus- hemmer
MX2009009174A (es) Inhibidores de serina-proteasas para el tratamiento de infecciones por el virus de hepatitis c.
ATE492559T1 (de) Makrocyclische peptide als hepatitis-c-virus- hemmer
WO2010034105A8 (en) Hepatitis c inhibitor compounds
WO2008070358A3 (en) N-cyclopropyl-hydroxyproline-based tripeptidic hepatitis c serine protease inhibitors containing an isoindole, pyrrolopyridine, pyrrolopyrimidine or pyrrolopyrazine heterocycle in the side chain
CY1118729T1 (el) Παραγωγα 9-μεθυλ υποκατεστημενου εξαδεκαϋδροκυκλοπροπα(ε)πυρρολο(1,2-α)(1,4)διαζακυκλοπενταδεκινυλ καρβαμικου ως μη δομικοι 3 (ns3) αναστολεις πρωτεασης για την αγωγη λοιμωξεων απο ιο ηπατιτιδας c

Legal Events

Date Code Title Description
FB Suspension of granting procedure